Paolini John F.
Insider CIK 1741533 · KNSA SVP & Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,497 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 1,624 | — | $0 | 1,624 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 1,750 | — | $0 | 3,500 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,457 | — | $0 | 7,371 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-09-01 | 2026-09-03 | 26,750 | — | $0 | 26,750 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-09-01 | 2026-09-03 | 6,700 | — | $0 | 6,700 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 2,497 | — | $0 | 68,120 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2026-09-01 | 2026-09-03 | 4,029 | $79.28 | $319.4K | 69,922 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 1,750 | — | $0 | 71,494 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 2,457 | — | $0 | 73,951 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 1,624 | — | $0 | 69,744 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,497 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 1,624 | — | $0 | 1,624 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 1,750 | — | $0 | 3,500 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,457 | — | $0 | 7,371 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-09-01 | 2026-09-03 | 26,750 | — | $0 | 26,750 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-09-01 | 2026-09-03 | 6,700 | — | $0 | 6,700 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2026-09-01 | 2026-09-03 | 4,029 | $79.28 | $319.4K | 69,922 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 2,457 | — | — | 73,951 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 1,750 | — | — | 71,494 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 1,624 | — | — | 69,744 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 2,497 | — | — | 68,120 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-05-01 | 2026-05-05 | 58,424 | — | $0 | 29,670 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-05-01 | 2026-05-05 | 58,424 | $10.36 | $605.3K | 124,047 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2026-05-01 | 2026-05-05 | 21,097 | $54.04 | $1.14M | 65,623 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2026-05-01 | 2026-05-05 | 37,327 | $53.52 | $2.00M | 86,720 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-04-07 | 2026-04-08 | 2,497 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2026-04-07 | 2026-04-08 | 1,208 | $48.94 | $59.1K | 65,623 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-04-07 | 2026-04-08 | 2,497 | — | $0 | 66,831 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-04-01 | 2026-04-03 | 2,457 | — | $0 | 7,371 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-04-01 | 2026-04-03 | 1,750 | — | $0 | 3,500 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-04-01 | 2026-04-03 | 1,624 | — | $0 | 1,624 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-04-01 | 2026-04-03 | 13,400 | — | $0 | 13,400 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-04-01 | 2026-04-03 | 26,750 | — | $0 | 26,750 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-04-01 | 2026-04-03 | 6,700 | — | $0 | 6,700 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-04-01 | 2026-04-03 | 5,831 | — | $0 | 67,155 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2026-04-01 | 2026-04-03 | 2,821 | $48.13 | $135.8K | 64,334 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-03-02 | 2026-03-04 | 40,000 | — | $0 | 58,424 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2026-03-02 | 2026-03-04 | 12,063 | $44.20 | $533.2K | 89,261 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2026-03-02 | 2026-03-04 | 22,223 | $44.88 | $997.4K | 67,038 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2026-03-02 | 2026-03-04 | 5,714 | $45.92 | $262.4K | 61,324 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-03-02 | 2026-03-04 | 40,000 | $10.36 | $414.4K | 101,324 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-10-31 | 2025-11-04 | 46,000 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-10-31 | 2025-11-04 | 36,542 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-10-31 | 2025-11-04 | 82,542 | $37.14 | $3.07M | 61,324 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-10-31 | 2025-11-04 | 46,000 | $8.83 | $406.2K | 143,866 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-10-31 | 2025-11-04 | 36,542 | $3.80 | $138.9K | 97,866 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-02 | 2025-09-03 | 1,725 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-02 | 2025-09-03 | 1,725 | — | $0 | 62,159 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-09-02 | 2025-09-03 | 835 | $34.28 | $28.6K | 61,324 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-09-01 | 2025-09-03 | 39,364 | — | $0 | 39,364 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-09-01 | 2025-09-03 | 9,828 | — | $0 | 9,828 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-01 | 2025-09-03 | 2,498 | — | $0 | 2,497 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-01 | 2025-09-03 | 1,624 | — | $0 | 3,248 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-01 | 2025-09-03 | 1,750 | — | $0 | 5,250 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-01 | 2025-09-03 | 1,750 | — | $0 | 59,153 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-01 | 2025-09-03 | 1,624 | — | $0 | 60,777 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-01 | 2025-09-03 | 2,498 | — | $0 | 63,275 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-09-01 | 2025-09-03 | 2,841 | $33.49 | $95.1K | 60,434 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-08-06 | 2025-08-08 | 29,325 | — | $0 | 36,542 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-08-06 | 2025-08-08 | 29,325 | $3.80 | $111.4K | 86,728 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-08-06 | 2025-08-08 | 29,325 | $32.55 | $954.5K | 57,403 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-05-07 | 2025-05-09 | 200 | — | $0 | 65,867 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-05-07 | 2025-05-09 | 200 | $27.00 | $5.4K | 57,403 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-05-07 | 2025-05-09 | 200 | $3.80 | $760 | 57,603 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-05-01 | 2025-05-05 | 5,201 | — | $0 | 5,201 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-05-01 | 2025-05-05 | 8,007 | — | $0 | 8,007 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-05-01 | 2025-05-05 | 8,266 | — | $0 | 8,266 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-05-01 | 2025-05-05 | 4,954 | — | $0 | 4,954 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-04-07 | 2025-04-09 | 2,498 | — | $0 | 2,497 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-04-07 | 2025-04-09 | 2,498 | — | $0 | 58,137 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-04-07 | 2025-04-09 | 734 | $20.28 | $14.9K | 57,403 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-04-01 | 2025-04-03 | 19,657 | — | $0 | 19,657 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-04-01 | 2025-04-03 | 9,828 | — | $0 | 9,828 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-04-01 | 2025-04-03 | 39,364 | — | $0 | 39,364 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-04-01 | 2025-04-03 | 1,750 | — | $0 | 5,250 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-04-01 | 2025-04-03 | 1,624 | — | $0 | 3,248 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-04-01 | 2025-04-03 | 1,624 | — | $0 | 54,880 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-04-01 | 2025-04-03 | 1,750 | — | $0 | 56,630 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-04-01 | 2025-04-03 | 477 | $21.77 | $10.4K | 56,153 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-04-01 | 2025-04-03 | 514 | $21.77 | $11.2K | 55,639 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-03-16 | 2025-03-19 | 1,725 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-03-16 | 2025-03-19 | 507 | $22.61 | $11.5K | 53,256 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-03-16 | 2025-03-19 | 1,725 | — | $0 | 53,763 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-09-03 | 2024-09-04 | 60,217 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-09-03 | 2024-09-04 | 475 | — | $0 | 44,549 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-09-03 | 2024-09-04 | 60,217 | $1.86 | $112.0K | 112,255 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2024-09-03 | 2024-09-04 | 1,478 | $27.13 | $40.1K | 52,038 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2024-09-03 | 2024-09-04 | 59,214 | $26.09 | $1.54M | 53,516 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-09-03 | 2024-09-04 | 475 | $3.80 | $1.8K | 112,730 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-09-02 | 2024-09-04 | 1,725 | — | $0 | 1,725 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2024-09-02 | 2024-09-04 | 835 | $26.74 | $22.3K | 52,038 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-09-02 | 2024-09-04 | 1,725 | — | $0 | 52,873 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-09-01 | 2024-09-04 | 1,624 | — | $0 | 4,872 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-09-01 | 2024-09-04 | 2,497 | — | $0 | 4,995 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2024-09-01 | 2024-09-04 | 36,350 | — | $0 | 36,350 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2024-09-01 | 2024-09-04 | 7,000 | — | $0 | 7,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-09-01 | 2024-09-04 | 4,121 | — | $0 | 53,142 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2024-09-01 | 2024-09-04 | 1,994 | $26.74 | $53.3K | 51,148 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-07-23 | 2024-07-25 | 22,000 | — | $0 | 60,217 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2024-07-23 | 2024-07-25 | 5,530 | $25.03 | $138.4K | 64,273 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-07-23 | 2024-07-25 | 22,000 | $1.86 | $40.9K | 69,803 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2024-07-23 | 2024-07-25 | 100 | $27.87 | $2.8K | 47,803 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2024-07-23 | 2024-07-25 | 8,446 | $27.10 | $228.9K | 47,903 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2024-07-23 | 2024-07-25 | 7,924 | $26.36 | $208.9K | 56,349 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2024-04-08 | 2024-04-08 | 2,497 | — | $0 | 9,375 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2024-04-08 | 2024-04-08 | 733 | $17.90 | $13.1K | 47,803 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2024-04-08 | 2024-04-08 | 2,497 | — | $0 | 48,536 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2024-04-04 | 2024-04-08 | 36,350 | — | $0 | 36,350 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2024-04-04 | 2024-04-08 | 7,000 | — | $0 | 11,872 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2024-04-04 | 2024-04-08 | 5,600 | — | $0 | 5,600 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2024-04-01 | 2024-04-03 | 1,624 | — | $0 | 4,872 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2024-04-01 | 2024-04-03 | 1,624 | — | $0 | 46,516 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2024-04-01 | 2024-04-03 | 477 | $19.70 | $9.4K | 46,039 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2024-03-01 | 2024-03-05 | 18,844 | — | $0 | 82,217 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2024-03-01 | 2024-03-05 | 18,844 | $1.86 | $35.0K | 62,736 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2024-03-01 | 2024-03-05 | 18,844 | $21.77 | $410.2K | 44,892 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2024-02-27 | 2024-02-29 | 10,156 | — | $0 | 101,061 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2024-02-27 | 2024-02-29 | 10,156 | $1.86 | $18.9K | 55,048 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2024-02-27 | 2024-02-29 | 10,156 | $21.03 | $213.6K | 44,892 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-12-07 | 2023-12-11 | 28,600 | — | $0 | 111,217 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2023-12-07 | 2023-12-11 | 7,380 | $17.54 | $129.4K | 66,112 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-12-07 | 2023-12-11 | 28,600 | $1.86 | $53.2K | 73,492 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2023-12-07 | 2023-12-11 | 1,501 | $17.81 | $26.7K | 44,892 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2023-12-07 | 2023-12-11 | 6,702 | $17.75 | $119.0K | 46,393 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2023-12-07 | 2023-12-11 | 13,017 | $17.64 | $229.6K | 53,095 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-09-05 | 2023-09-06 | 400 | — | $0 | 139,817 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2023-09-05 | 2023-09-06 | 400 | $17.53 | $7.0K | 44,892 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-09-05 | 2023-09-06 | 400 | $1.86 | $744 | 45,292 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-09-02 | 2023-09-06 | 1,725 | — | $0 | 3,450 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-09-02 | 2023-09-06 | 1,725 | — | $0 | 45,399 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2023-09-02 | 2023-09-06 | 507 | $17.76 | $9.0K | 44,892 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-09-01 | 2023-09-06 | 6,496 | — | $0 | 6,496 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-09-01 | 2023-09-06 | 2,498 | — | $0 | 7,492 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-09-01 | 2023-09-06 | 38,974 | — | $0 | 38,974 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2023-09-01 | 2023-09-06 | 734 | $17.76 | $13.0K | 43,674 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-09-01 | 2023-09-06 | 2,498 | — | $0 | 44,408 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-07-25 | 2023-07-27 | 29,000 | — | $0 | 140,217 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2023-07-25 | 2023-07-27 | 5,200 | $18.01 | $93.7K | 65,710 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2023-07-25 | 2023-07-27 | 16,168 | $19.25 | $311.2K | 49,542 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2023-07-25 | 2023-07-27 | 7,632 | $19.69 | $150.3K | 41,910 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-07-25 | 2023-07-27 | 29,000 | $1.86 | $53.9K | 70,910 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-04-10 | 2023-04-11 | 2,498 | — | $0 | 7,492 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2023-04-10 | 2023-04-11 | 734 | $10.71 | $7.9K | 41,910 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-04-10 | 2023-04-11 | 2,498 | — | $0 | 42,644 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-04-01 | 2023-04-03 | 38,974 | — | $0 | 38,974 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-04-01 | 2023-04-03 | 6,496 | — | $0 | 6,496 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-03-20 | 2023-03-20 | 3,671 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2023-03-20 | 2023-03-20 | 1,078 | $11.12 | $12.0K | 40,146 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-03-20 | 2023-03-20 | 3,671 | — | $0 | 41,224 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-03-16 | 2023-03-20 | 1,725 | — | $0 | 3,450 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-03-16 | 2023-03-20 | 1,725 | — | $0 | 38,060 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2023-03-16 | 2023-03-20 | 507 | $11.46 | $5.8K | 37,553 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2022-11-07 | 2022-11-09 | 28,357 | — | $0 | 169,217 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2022-11-07 | 2022-11-09 | 28,357 | $15.18 | $430.5K | 36,335 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2022-11-07 | 2022-11-09 | 28,357 | $1.86 | $52.7K | 64,692 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2022-09-02 | 2022-09-06 | 1,725 | — | $0 | 5,175 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2022-09-02 | 2022-09-06 | 507 | $11.44 | $5.8K | 36,335 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2022-09-02 | 2022-09-06 | 1,725 | — | $0 | 36,842 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-09-01 | 2022-09-06 | 59,930 | — | $0 | 59,930 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-09-01 | 2022-09-06 | 9,990 | — | $0 | 9,990 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-04-07 | 2022-04-11 | 9,990 | — | $0 | 9,990 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-04-07 | 2022-04-11 | 59,930 | — | $0 | 59,930 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2022-03-21 | 2022-03-23 | 5,676 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2022-03-21 | 2022-03-23 | 1,686 | $10.98 | $18.5K | 35,117 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2022-03-21 | 2022-03-23 | 5,676 | — | $0 | 36,803 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2022-03-16 | 2022-03-18 | 1,725 | — | $0 | 5,175 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2022-03-16 | 2022-03-18 | 598 | $10.13 | $6.1K | 31,127 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2022-03-16 | 2022-03-18 | 1,725 | — | $0 | 31,725 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-09-02 | 2021-09-07 | 6,900 | — | $0 | 6,900 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-09-02 | 2021-09-07 | 41,400 | — | $0 | 41,400 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-03-20 | 2021-03-23 | 3,671 | — | $0 | 3,671 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-03-20 | 2021-03-23 | 5,676 | — | $0 | 5,676 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-03-16 | 2021-03-18 | 41,400 | — | $0 | 41,400 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-03-16 | 2021-03-18 | 6,900 | — | $0 | 6,900 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2020-09-10 | 2020-09-14 | 50,000 | — | $0 | 50,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2020-03-13 | 2020-03-17 | 50,000 | — | $0 | 50,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2020-02-27 | 2020-03-02 | 12,000 | — | $0 | 197,574 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2020-02-27 | 2020-03-02 | 12,000 | $1.86 | $22.3K | 30,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2020-02-20 | 2020-02-21 | 9,803 | — | $0 | 66,542 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2020-02-20 | 2020-02-21 | 9,803 | $3.80 | $37.3K | 27,803 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2020-02-20 | 2020-02-21 | 8,687 | $18.91 | $164.3K | 19,116 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2020-02-20 | 2020-02-21 | 1,116 | $19.32 | $21.6K | 18,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2020-02-19 | 2020-02-21 | 22,477 | — | $0 | 76,345 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2020-02-19 | 2020-02-21 | 22,477 | $18.27 | $410.7K | 18,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2020-02-19 | 2020-02-21 | 22,477 | $3.80 | $85.4K | 40,477 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2020-02-14 | 2020-02-18 | 1,039 | — | $0 | 98,822 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2020-02-14 | 2020-02-18 | 1,039 | $18.33 | $19.0K | 18,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2020-02-14 | 2020-02-18 | 1,039 | $3.80 | $3.9K | 19,039 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2020-02-13 | 2020-02-18 | 10,277 | — | $0 | 99,861 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2020-02-13 | 2020-02-18 | 10,277 | $18.29 | $188.0K | 18,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2020-02-13 | 2020-02-18 | 10,277 | $3.80 | $39.1K | 28,277 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2019-12-05 | 2019-12-09 | 8,000 | — | $0 | 209,574 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2019-12-05 | 2019-12-09 | 8,000 | $1.86 | $14.9K | 8,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2019-10-07 | 2019-10-09 | 10,000 | — | $0 | 217,574 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2019-10-07 | 2019-10-09 | 10,000 | $1.86 | $18.6K | 10,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2019-09-17 | 2019-09-19 | 46,000 | — | $0 | 46,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2019-03-04 | 2019-03-06 | 51,000 | — | $0 | 51,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2018-09-20 | 2018-09-24 | 45,000 | — | $0 | 45,000 | SEC↗ |